R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate School of Medicine from Hokkaido University. The research is in the application of a new VAP-1 inhibitor (Development Code: RTU-1096), which is under our development for treatment of diabetic retinopathy (DR) and diabetic macular edema. RTU-1096 is a
